Farmakokinetiske interaktioner In vitro- data viser, at fesoterodins aktive metabolit ikke hæmmer CYP1A2, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1 eller 3A4 eller inducerer CYP1A2, 2B6, 2C9, 2C19 eller 3A4 ved klinisk relevante plasmakoncentrationer.
Pharmacokinetic interactions In vitro data demonstrate that the active metabolite of fesoterodine does not inhibit CYP1A2, 2B6, 2C8, 2C9, 2C19, 2D6, 2E1, or 3A4, or induce CYP1A2, 2B6, 2C9, 2C19, or 3A4 at clinically relevant plasma concentrations.